Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

STD Preventive Services

The Affordable Care Act requires coverage of recommended preventive services without cost-sharing for the following health plans:

  1. Non-grandfathered private health insurance plans – Most private insurance plans, including all plans on the Health Insurance Marketplace, and all group or individual health insurance plans that did not exist on March 23, 2010 or that have made significant changes to benefits, cost-sharing, or limits since that time are required to cover services without cost-sharing.1
  2. Medicare – All USPSTF recommended services that have a Grade “A” or “B” and that are covered by Medicare must be covered without cost-sharing.2
  3. Medicaid expansion plans in states that expanded (i.e. Alternative Benefit Plans) – Medicaid expansion plans offered by states that extend Medicaid eligibility to non-elderly individuals with annual incomes at or below 133 percent of the federal poverty level ($15,880 for an individual or $32,319 for a family of 4 in 2016) are required to cover services without cost-sharing.3,4
  4. Traditional Medicaid plans – Those states that, at their option, cover without cost-sharing in their standard Medicaid benefit package all USPSTF-recommended services that have a Grade “A” or “B” and all ACIP-recommended vaccines receive an increase in their federal medical assistance for such services and vaccines.5

In addition to these services, private and public plans may cover other preventive services without cost-sharing.

Preventive Service

Recommending Authority
(authorized under Section 1001 of the Patient Protection and Affordable Care Act)

Eligible Populations and Service Specifics

Health Insurance Plans That Cover the Service Without Cost-Sharing

Chlamydia Screening

USPSTF
(Grade “B” recommendation for non-pregnant women issued June 2014 and Grade “B” recommendation for pregnant women issued June 2007)

The USPSTF recommends screening for chlamydia in sexually active women age 24 years and younger and in older women who are at increased risk for infection. This also applies to pregnant women.6

(See Final Recommendation Statement: Chlamydia and Gonorrhea: Screening - US Preventive Services Task Force for additional information.)

  • Non-grandfathered private health insurance plans
  • Medicare
    Medicare covers chlamydia screenings for pregnant women who are 24 years old or younger when the diagnosis of pregnancy is known, and then repeat screening during the third trimester if high-risk sexual behavior has occurred since the initial screening test; pregnant women who are at increased risk for STIs when the diagnosis of pregnancy is known, and then repeat screening during the third trimester if high-risk sexual behavior has occurred since the initial screening test; and women at increased risk for STIs annually.8
  • Medicaid expansion plans
  • Traditional Medicaid plans
    Optional as above.

Bright Futures
Recommendations for Pediatric Preventive Health Care, Supported by HRSA

(Recommendations issued 2008 by the American Academy of Pediatrics)

STI screening for sexually active adolescents (11-21 years of age) as per recommendations in current edition of AAP Red Book.7

  • Non-grandfathered private health insurance plans
  • Medicaid expansion plans
  • Traditional Medicaid plans
    Optional as above. In general, preventive services for children are covered Included as part of the Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) benefit for children; cost-sharing may apply in some cases.

Syphilis Testing

USPSTF
(Grade “A” recommendation for non-pregnant adults and adolescent women issued June 2016 and Grade “A” recommendation for pregnant women issued May 2009)

Screening persons at increased risk for syphilis infection.9

Screening all pregnant women for syphilis infection.10

(See Final Update Summary: Syphilis Infection in Nonpregnant Adults and Adolescents: Screening - US Preventive Services Task Force for additional information.)

  • Non-grandfathered private health insurance plans
  • Medicare
    Medicare covers syphilis screenings for pregnant women when the diagnosis of pregnancy is known, and then repeat screening during the third trimester and at delivery if high-risk sexual behavior has occurred since the previous screening test; and men and women at increased risk for STIs annually.8
  • Medicaid expansion plans
  • Traditional Medicaid plans
    Optional as above.

Bright Futures
Recommendations for Pediatric Preventive Health Care, Supported by HRSA

(Recommendations issued 2008 by the American Academy of Pediatrics)

STI screening test for sexually active adolescents (11-21 years of age) as per recommendations current Red Book.

  • Non-grandfathered private health insurance plans
  • Medicaid expansion plans
  • Traditional Medicaid plans
    Optional as above. In general, preventive services for children are covered Included as part of the Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) benefit for children; cost-sharing may apply in some cases.

Gonorrhea Testing

USPSTF
(Grade “B” recommendation issued September 2014)

The USPSTF recommends screening for gonorrhea in sexually active women age 24 years and younger and in older women who are at increased risk for infection. This also applies to pregnant women.6

(See Final Recommendation Statement: Chlamydia and Gonorrhea: Screening - US Preventive Services Task Force for additional information.)

  • Non-grandfathered private health insurance plans
  • Medicare
    Medicare covers gonorrhea screenings for pregnant women who are 24 years old or younger when the diagnosis of pregnancy is known, and then repeat screening during the third trimester if high-risk sexual behavior has occurred since the initial screening test; pregnant women who are at increased risk for STIs when the diagnosis of pregnancy is known, and then repeat screening during the third trimester if high-risk sexual behavior has occurred since the initial screening test; and women at increased risk for STIs annually.7
  • Medicaid expansion plans
  • Traditional Medicaid plans
    Optional as above.

Bright Futures
Recommendations for Pediatric Preventive Health Care, Supported by HRSA

(Recommendations issued 2008 by the American Academy of Pediatrics)

STI screening for sexually active adolescents (11-21 years of age) as per recommendations current Red Book.7

  • Non-grandfathered private health insurance plans
  • Medicaid expansion plans
  • Traditional Medicaid plans
    Optional as above. In general, preventive services for children are covered Included as part of the Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) benefit for children; cost-sharing may apply in some cases.

Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum

USPSTF
(Grade “A” recommendation issued July 2011)

Prophylactic ocular topical medication for all newborns for the prevention of gonococcal ophthalmia neonatorum.11

(See USPSTF – Clinical Considerations for Ocular Prophylaxis for Gonococcal Opthalmia Neonatorum for additional information.)

  • Non-grandfathered private health insurance plans
  • Medicaid expansion plans
  • Traditional Medicaid plans
    Optional as above.

Human Papillomavirus Testing

HRSA – Women’s Preventive Services
(Coverage guidelines adopted August 1, 2011)

High-risk human papillomavirus DNA testing in women with normal cytology results.

Screening should begin at 30 years of age and should occur no more frequently than every 3 years.12

(See Clinical Preventive Services for Women: Closing the Gaps for additional information.)

  • Non-grandfathered private health insurance plans
  • Medicaid expansion plans

Human Papillomavirus Vaccination

Advisory Committee on Immunization Practices (ACIP)
(Latest recommendations issued and adopted by the Director of the Centers for Disease Control and Prevention, March 2015)

9-valent, 4-valent, or 2-valent HPV vaccines can be used for routine vaccination of females 11 or 12 years, and females 12-26 years who haven’t been vaccinated previously or who have not completed the 3-dose series.

9-valent or 4-valent HPV vaccine can be used for routine vaccination of males 11 or 12 years and males through 21 years who have not been vaccinated previously or who have not completed the 3-dose series.
9-valent or 4-valent vaccine can be used for MSM and immunocompromised persons through 26 years if not vaccinated previously.13

  • Non-grandfathered private health insurance plans
  • Medicaid expansion plans
  • Traditional Medicaid plans
    Optional as above.

Sexually Transmitted Infection (STI) and HIV Prevention Counseling

USPSTF
(Grade “B” recommendation issued September 2014)

Intensive behavioral counseling to prevent sexually transmitted infections (STIs) for all sexually active adolescents and for adults at increased risk for STIs.14

(See USPSTF Clinical Considerations for Behavioral Counseling to Prevent STIs for a discussion of risk factors.)

  • Non-grandfathered private health insurance plans
  • Medicare
    Medicare will cover up to two individual 20 to 30 minute, face to face counseling sessions annually for Medicare beneficiaries for HIBC to prevent STIs for all sexually active adolescents and for adults at increased risk for STIs, if referred for this service by a primary care provider and provided by a Medicare eligible primary care provider in a primary care setting.7
  • Medicaid expansion plans
  • Traditional Medicaid plans
    Optional as above.

HRSA – Women’s Preventive Services
(Coverage guidelines adopted August 1, 2011, and updated December 20, 2016)

Annual counseling on sexually transmitted infections for all sexually active women.

Annual counseling for HIV infection for all sexually active women.12

(See Clinical Preventive Services for Women: Closing the Gaps for additional information.)

  • Non-grandfathered private health insurance plans
  • Medicaid expansion plans

NOTE: Programs in states that are implementing “alternative” means to expand Medicaid (i.e. expanding Medicaid through “premium assistance”) should be mindful of state decisions regarding coverage and cost-sharing of these preventive services for newly eligible Medicaid enrollees.

6 Final Recommendation Statement: Chlamydia and Gonorrhea: Screening. December 2014. U.S. Preventive Services Task Force.

7 2016 Recommendations for Preventive Pediatric Health Care. Committee on Practice and Ambulatory Medicine and Bright Futures Periodicity Schedule Workgroup. Pediatrics 2016;137.

8 Pub 100-03 Medicare National Coverage Determinations. Chapter 1, Section 210.10. Centers for Medicare and Medicaid Services. Issued 2012 January 26.

9 Final Recommendation Statement: Syphilis Infection in Nonpregnant Adults and Adolescents: Screening. June 2016. U.S. Preventive Services Task Force.

10 Final Evidence Review: Syphilis Infection in Pregnancy: Screening. U.S. Preventive Services Task Force.

11 Final Evidence Review: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication. U.S. Preventive Services Task Force. July 2011.

12 Women’s Preventive Services: Required Health Plan Coverage Guidelines. Health Resources and Services Administration.

13 Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices. Centers for Disease Control and Prevention. MMWR March 27, 2015 / 64(11);300-304.

14 Final Recommendation Statement: Sexually Transmitted Infections: Behavioral Counseling. December 2014. U.S. Preventive Services Task Force.

Top